Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 241 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-CEPHALEXIN | 500MG | CAPSULE | Resolved | 2022-09-07 | 2023-07-28 | 168722 |
TEVA-CEPHALEXIN | 500MG | TABLET | Resolved | 2022-09-07 | 2023-04-28 | 168726 |
TEVA-CLOXACILLIN | 250MG | CAPSULE | Resolved | 2022-09-07 | 2022-09-23 | 168729 |
TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2022-09-07 | 2023-10-05 | 168733 |
TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2022-09-07 | 2022-10-01 | 168737 |
TEVA-PROPRANOLOL | 40MG | TABLET | Resolved | 2022-09-07 | 2023-01-12 | 168741 |
TEVA-RISPERIDONE | 3.0MG | TABLET | Resolved | 2022-09-07 | 2022-12-22 | 168744 |
TEVA-SIMVASTATIN | 10MG | TABLET | Resolved | 2022-09-07 | 2023-06-21 | 168749 |
TEVA-OLANZAPINE | 5MG | TABLET | Resolved | 2022-09-22 | 2022-10-01 | 169948 |
TEVA-PRAZOSIN | 1MG | TABLET | Resolved | 2022-09-22 | 2022-10-01 | 169951 |
TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2022-09-22 | 2022-12-22 | 169957 |
TEVA-BETAMETHASONE/ CALCIPOTRIOL | 50MCG 0.5MG | OINTMENT | Resolved | 2022-09-22 | 2022-12-02 | 169961 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2022-09-22 | 2024-02-14 | 169966 |
TEVA-NABILONE | 0.25MG | CAPSULE | Resolved | 2022-09-22 | 2023-04-28 | 169973 |
TEVA-PROPRANOLOL | 10MG | TABLET | Resolved | 2022-09-22 | 2023-01-19 | 169978 |
TEVA-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-09-22 | 2023-04-28 | 169983 |
ACT ESCITALOPRAM ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-09-22 | 2023-06-09 | 169990 |
ACT ESCITALOPRAM ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-09-22 | 2023-06-09 | 169995 |
TEVA-RISPERIDONE | 1.0MG | TABLET | Resolved | 2022-09-22 | 2022-12-22 | 170004 |
ACT EXEMESTANE | 25MG | TABLET | Resolved | 2022-09-22 | 2023-01-19 | 170011 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |